Further, combined immunohistochemical and in-situ hybridization analysis revealed that most MDS patients and some AML patients with multilineage dysplasia (MLD) displayed reduced levels of TET2, which was directly anti-correlated with miR-22 expression level and associated with worse prognosis. The gene discussed is TET2; the disease is myelodysplastic syndrome.